Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases

Dongkyu Kim, Gun Sik Cho, Choongseong Han, Dong-Hyuk Park, Hee Kyung Park, Dong Hun Woo, Jong-Hoon Kim

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Liver failure is one of the main risks of death worldwide, and it originates from repetitive injuries and inflammations of liver tissues, which finally leads to the liver cirrhosis or cancer. Currently, liver transplantation is the only effective treatment for the liver diseases although it has a limitation due to donor scarcity. Alternatively, cell therapy to regenerate and reconstruct the damaged liver has been suggested to overcome the current limitation of liver disease cures. Several transplantable cell types could be utilized for recovering liver functions in injured liver, including bone marrow cells, mesenchymal stem cells, hematopoietic stem cells, macrophages, and stem cell-derived hepatocytes. Furthermore, paracrine effects of transplanted cells have been suggested as a new paradigm for liver disease cures, and this application would be a new strategy to cure liver failures. Therefore, here we reviewed the current status and challenges of therapy using stem cells for liver disease treatments.

Original languageEnglish
Pages (from-to)653-665
Number of pages13
JournalTissue Engineering and Regenerative Medicine
Volume14
Issue number6
DOIs
Publication statusPublished - 2017 Dec 1

Fingerprint

Cell- and Tissue-Based Therapy
Stem cells
Liver
Liver Diseases
Stem Cells
Liver Failure
Liver Neoplasms
Hematopoietic Stem Cells
Mesenchymal Stromal Cells
Bone Marrow Cells
Liver Cirrhosis
Liver Transplantation
Hepatocytes
Therapeutics
Macrophages
Inflammation
Wounds and Injuries
Bone
Cells
Tissue

Keywords

  • Liver failure
  • Liver regeneration
  • Secretome
  • Stem cell transplantation

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biomedical Engineering

Cite this

Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases. / Kim, Dongkyu; Cho, Gun Sik; Han, Choongseong; Park, Dong-Hyuk; Park, Hee Kyung; Woo, Dong Hun; Kim, Jong-Hoon.

In: Tissue Engineering and Regenerative Medicine, Vol. 14, No. 6, 01.12.2017, p. 653-665.

Research output: Contribution to journalReview article

Kim, Dongkyu ; Cho, Gun Sik ; Han, Choongseong ; Park, Dong-Hyuk ; Park, Hee Kyung ; Woo, Dong Hun ; Kim, Jong-Hoon. / Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases. In: Tissue Engineering and Regenerative Medicine. 2017 ; Vol. 14, No. 6. pp. 653-665.
@article{768fd1ea9f7b41c1a020a6d282fdfe88,
title = "Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases",
abstract = "Liver failure is one of the main risks of death worldwide, and it originates from repetitive injuries and inflammations of liver tissues, which finally leads to the liver cirrhosis or cancer. Currently, liver transplantation is the only effective treatment for the liver diseases although it has a limitation due to donor scarcity. Alternatively, cell therapy to regenerate and reconstruct the damaged liver has been suggested to overcome the current limitation of liver disease cures. Several transplantable cell types could be utilized for recovering liver functions in injured liver, including bone marrow cells, mesenchymal stem cells, hematopoietic stem cells, macrophages, and stem cell-derived hepatocytes. Furthermore, paracrine effects of transplanted cells have been suggested as a new paradigm for liver disease cures, and this application would be a new strategy to cure liver failures. Therefore, here we reviewed the current status and challenges of therapy using stem cells for liver disease treatments.",
keywords = "Liver failure, Liver regeneration, Secretome, Stem cell transplantation",
author = "Dongkyu Kim and Cho, {Gun Sik} and Choongseong Han and Dong-Hyuk Park and Park, {Hee Kyung} and Woo, {Dong Hun} and Jong-Hoon Kim",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s13770-017-0093-7",
language = "English",
volume = "14",
pages = "653--665",
journal = "Tissue Engineering and Regenerative Medicine",
issn = "1738-2696",
publisher = "Springer Science + Business Media",
number = "6",

}

TY - JOUR

T1 - Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases

AU - Kim, Dongkyu

AU - Cho, Gun Sik

AU - Han, Choongseong

AU - Park, Dong-Hyuk

AU - Park, Hee Kyung

AU - Woo, Dong Hun

AU - Kim, Jong-Hoon

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Liver failure is one of the main risks of death worldwide, and it originates from repetitive injuries and inflammations of liver tissues, which finally leads to the liver cirrhosis or cancer. Currently, liver transplantation is the only effective treatment for the liver diseases although it has a limitation due to donor scarcity. Alternatively, cell therapy to regenerate and reconstruct the damaged liver has been suggested to overcome the current limitation of liver disease cures. Several transplantable cell types could be utilized for recovering liver functions in injured liver, including bone marrow cells, mesenchymal stem cells, hematopoietic stem cells, macrophages, and stem cell-derived hepatocytes. Furthermore, paracrine effects of transplanted cells have been suggested as a new paradigm for liver disease cures, and this application would be a new strategy to cure liver failures. Therefore, here we reviewed the current status and challenges of therapy using stem cells for liver disease treatments.

AB - Liver failure is one of the main risks of death worldwide, and it originates from repetitive injuries and inflammations of liver tissues, which finally leads to the liver cirrhosis or cancer. Currently, liver transplantation is the only effective treatment for the liver diseases although it has a limitation due to donor scarcity. Alternatively, cell therapy to regenerate and reconstruct the damaged liver has been suggested to overcome the current limitation of liver disease cures. Several transplantable cell types could be utilized for recovering liver functions in injured liver, including bone marrow cells, mesenchymal stem cells, hematopoietic stem cells, macrophages, and stem cell-derived hepatocytes. Furthermore, paracrine effects of transplanted cells have been suggested as a new paradigm for liver disease cures, and this application would be a new strategy to cure liver failures. Therefore, here we reviewed the current status and challenges of therapy using stem cells for liver disease treatments.

KW - Liver failure

KW - Liver regeneration

KW - Secretome

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=85037065222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037065222&partnerID=8YFLogxK

U2 - 10.1007/s13770-017-0093-7

DO - 10.1007/s13770-017-0093-7

M3 - Review article

AN - SCOPUS:85037065222

VL - 14

SP - 653

EP - 665

JO - Tissue Engineering and Regenerative Medicine

JF - Tissue Engineering and Regenerative Medicine

SN - 1738-2696

IS - 6

ER -